cUV-3

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NamecUV-3
Drug Alias Nameanti CD-54 monoclonal antibody (Abiogen)anti ICAM-1 monoclonal antibody (Abiogen)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionIntercellular adhesion molecule-1 inhibitors
TargetsIntercellular adhesion molecule-1
Therapy Area/IndicationsUveal melanomaMultiple MyelomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbiogen Pharma Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbiogen Pharma Spa
Active IndicationsN/A
Inactive IndicationsUveal melanomaMultiple MyelomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A